Capacity Bio

The Mitophagy Company

Los Angeles, United States · $35.0M raised

Employees
1–10
Business Model
B2B
Total Funding
$35.0M
Last Round
$35.0M Series AMar 2023
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Capacity Bio is a mitochondria-focused biotechnology company developing first-in-class therapeutics that enhance the body's mitophagy process — the cellular mechanism by which dysfunctional mitochondria are identified, removed, and replaced. The company's proprietary platform uses small molecules, peptides, and nanoparticles to activate mitophagy pathways implicated in aging, neurodegeneration, and metabolic disease. Headquartered in Los Angeles and with a Japanese subsidiary in Tokyo, Capacity Bio closed a $35 million financing round in March 2023 co-led by RA Capital Management and Insight Partners, with participation from existing investor Remiges Ventures. Its lead mitophagy agonist program was advancing toward clinical trials in 2024.

Summary

Capacity Bio is a Life Sciences company based in Los Angeles, United States. It has raised $35.0M in total across 1 round, most recently a $35.0M Series A round in Mar 2023. Investors include RA Capital Management, Insight Partners and Remiges Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMar 2023
$35.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Capacity Bio on Indexed.vc
<a href="https://indexed.vc/companies/capacity-bio"><img src="https://indexed.vc/api/badge/company/capacity-bio" alt="Capacity Bio on Indexed.vc" width="260" height="76" /></a>